Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis

Ruoqiong Cao, Garrett Teskey, Hicret Islamoglu, Rachel Abrahem, Shalok Munjal, Karo Gyurjian, Vishwanath Venketaraman

Antimicrobial Agents and Chemotherapy · 2018 · 33 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

Mycobacterium tuberculosis is the etiological agent that is responsible for causing tuberculosis (TB), which continues to affect millions of people worldwide, and the rate of resistance of M. tuberculosis to antibiotics is ever increasing. We tested the synergistic effects of N -acetyl cysteine (NAC; the precursor molecule for the synthesis of glutathione [GSH]) and individual first-line antibiotics typically given for the treatment of TB, such as isoniazid (INH), rifampin (RIF), ethambutol (EMB), and pyrazinamide (PZA), to improve the ability of macrophages to control intracellular M. tuberculosis infection.

References

25